ANTONAZZO, IPPAZIO COSIMO
 Distribuzione geografica
Continente #
NA - Nord America 6.708
AS - Asia 5.801
EU - Europa 3.616
SA - Sud America 763
Continente sconosciuto - Info sul continente non disponibili 307
AF - Africa 142
OC - Oceania 9
Totale 17.346
Nazione #
US - Stati Uniti d'America 6.378
SG - Singapore 1.896
IT - Italia 1.507
VN - Vietnam 1.191
CN - Cina 922
HK - Hong Kong 805
RU - Federazione Russa 602
BR - Brasile 554
DE - Germania 393
IE - Irlanda 205
FR - Francia 198
CA - Canada 192
GB - Regno Unito 165
BD - Bangladesh 163
IN - India 154
KR - Corea 147
SE - Svezia 128
ID - Indonesia 117
FI - Finlandia 79
AR - Argentina 77
NL - Olanda 76
IQ - Iraq 61
ZA - Sudafrica 51
MX - Messico 45
ES - Italia 44
TR - Turchia 42
JP - Giappone 39
PL - Polonia 39
PH - Filippine 38
AT - Austria 37
SA - Arabia Saudita 37
CO - Colombia 32
EC - Ecuador 31
PK - Pakistan 31
UA - Ucraina 29
MY - Malesia 26
VE - Venezuela 24
CH - Svizzera 22
EG - Egitto 18
JM - Giamaica 17
MA - Marocco 17
UZ - Uzbekistan 17
CL - Cile 15
AE - Emirati Arabi Uniti 14
AL - Albania 14
CR - Costa Rica 14
CZ - Repubblica Ceca 14
IR - Iran 13
KE - Kenya 13
TN - Tunisia 13
ET - Etiopia 10
GT - Guatemala 9
IL - Israele 9
NP - Nepal 9
PY - Paraguay 9
AU - Australia 8
HN - Honduras 8
JO - Giordania 8
SV - El Salvador 8
TW - Taiwan 8
UY - Uruguay 8
PE - Perù 7
DZ - Algeria 6
KZ - Kazakistan 6
LT - Lituania 6
PT - Portogallo 6
QA - Qatar 6
TH - Thailandia 6
TT - Trinidad e Tobago 6
BE - Belgio 5
DO - Repubblica Dominicana 5
MN - Mongolia 5
NI - Nicaragua 5
OM - Oman 5
PA - Panama 5
BG - Bulgaria 4
BO - Bolivia 4
CW - ???statistics.table.value.countryCode.CW??? 4
EE - Estonia 4
HR - Croazia 4
LB - Libano 4
MD - Moldavia 4
PS - Palestinian Territory 4
RO - Romania 4
BH - Bahrain 3
BY - Bielorussia 3
DK - Danimarca 3
GP - Guadalupe 3
GR - Grecia 3
KG - Kirghizistan 3
LU - Lussemburgo 3
LV - Lettonia 3
PR - Porto Rico 3
RS - Serbia 3
AM - Armenia 2
AZ - Azerbaigian 2
BB - Barbados 2
BW - Botswana 2
BZ - Belize 2
CG - Congo 2
Totale 17.007
Città #
Singapore 1.125
Hong Kong 789
Ashburn 748
San Jose 654
Milan 415
Ho Chi Minh City 367
Ann Arbor 345
Hanoi 323
Hefei 277
Council Bluffs 257
Dallas 230
Frankfurt am Main 213
New York 208
Dublin 195
Los Angeles 181
Santa Clara 170
Chicago 146
Seoul 140
The Dalles 139
Chandler 125
Rome 123
Beijing 103
Toronto 100
Lauterbourg 78
Jakarta 75
São Paulo 71
Buffalo 65
Boardman 64
Munich 63
Moscow 60
London 58
Seattle 55
Columbus 49
Helsinki 49
Bologna 43
Fairfield 43
Nuremberg 43
Princeton 43
Phoenix 42
Denver 39
Da Nang 38
Tokyo 35
Haiphong 34
Brooklyn 33
Wilmington 33
Atlanta 32
Houston 32
Ha Long 31
Turin 31
Warsaw 30
Washington 30
Orem 29
Baghdad 28
Rio de Janeiro 27
Perugia 26
Thái Nguyên 26
Verona 26
Altamura 25
Biên Hòa 25
Can Tho 23
Naples 23
Ninh Bình 23
Parma 23
Shanghai 23
Florence 22
Salt Lake City 22
Chennai 20
Montreal 20
Philadelphia 20
San Francisco 20
Johannesburg 19
Figino 18
Lappeenranta 18
Lawrence 18
Palermo 18
San Diego 18
Jeddah 17
Mexico City 17
Stockholm 17
Woodbridge 17
Quận Bình Thạnh 16
Zurich 16
Boston 15
Tashkent 15
Vienna 15
Dhaka 14
Hải Dương 14
Mumbai 14
Osasco 14
Roubaix 14
Amsterdam 13
Cambridge 13
Charlotte 13
Guangzhou 13
Hangzhou 13
Madrid 13
Biloxi 12
Brasília 12
Kent 12
Kuala Lumpur 12
Totale 9.573
Nome #
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 777
Epidemiology of SLE in Italy: an observational study using a primary care database 588
Costs and effects of cardiovascular risk reclassification using the ankle-brachial index (ABI) in addition to the Framingham risk scoring in women 506
Health and economic impact of dapagliflozin for type 2 diabetes patients who had or were at risk for atherosclerotic cardiovascular disease in the Italian general practitioners setting: a budget impact analysis 414
Incidence and risk factors for falls among nursing home residents in Italy: a retrospective cohort study 407
Knowledge, Attitudes and Practices Survey of Recombinant Zoster Vaccine among Cardiologists and Cardiac Nurses in Italy 355
Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019 339
Time-Trends in Air Pollution Impact on Health in Italy, 1990–2019: An Analysis From the Global Burden of Disease Study 2019 317
Azithromycin use and outcomes in patients with COVID-19: an observational real-world study 317
Farmacoutilizzazione della terapia per la gestione del paziente con tremore essenziale: uno studio di coorte retrospettivo condotto utilizzando i database dei medici di medicina generale di Regno unito e Francia 297
Generalizability and treatment with sodium-glucose co-trasporter-2 inhibitors (SGLT2i) among patients with type 2 diabetes: an assessment using an Italian primary care database 290
Hepatitis B vaccination and the putative risk of central demyelinating diseases – A systematic review and meta-analysis 288
Treatment patterns in essential tremor: Real-world evidence from a United Kingdom and France primary care database 287
Cost and Cost Effectiveness of Treatments for Psoriatic Arthritis: An Updated Systematic Literature Review 284
COVID-19 outbreak impact on anticoagulants utilization: an interrupted time-series analysis using healthcare administrative databases 281
Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019 273
PCSK9 Inhibitors’ New Users: Analysis of Prescription Patterns and Patients’ Characteristics from an Italian Real-world Study 273
Il carico di malattia associato ai virus dell'epatite B e C in Europa. Dati dal Global Burden of Disease Study 2019 269
Haemophilia management and treatment: An Italian survey on patients’, caregivers’ and clinicians’ point of view 266
Azithromycin use and covid-19: a real-world observational study. 264
A Cross-Indication Budget Impact Model of Secukinumab for the Treatment of Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis in Italy 263
The psychosocial impact of haemophilia from patients’ and caregivers’ point of view: The results of an Italian survey 260
COVID-19 e suicidio: uno studio retrospettivo sul territorio di Bergamo e provincia 257
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study 255
Immunogenicity of Recombinant Zoster Vaccine: A Systematic Review, Meta-Analysis, and Meta-Regression 250
Patterns and trends of idarucizumab use in an Italian region: a probabilistic record-linkage approach in a real-life setting 245
Antidepressants Drug Use during COVID-19 Waves in the Tuscan General Population: An Interrupted Time-Series Analysis 245
Statins Use in Patients with Cardiovascular Diseases and COVID-19 Outcomes: An Italian Population-Based Cohort Study 239
The Value of Tucatinib in Metastatic HER2-Positive Breast Cancer Patients: An Italian Cost-Effectiveness Analysis 236
Real-World Clinical Outcomes and Replacement Factor VIII Consumption in Patients with Haemophilia A in Italy: A Comparison between Prophylaxis Pre and Post Octocog Alfa (BAY 81-8973) 231
Personalized Prophylaxis with myPKFiTCE: A Real-World Cost-Effectiveness Analysis in Haemophilia A Patients 231
Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1 228
Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy 226
Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up 222
Association between azithromycin use and clinical outcomes in COVID-19 patients: an Italian observational study 217
Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019 217
A cost-consequence analysis of adding pertuzumab to the neoadjuvant combination therapy in HER2-positive high-risk early breast cancer in Italy 216
Valutazione dell’impatto della pandemia sugli accessi al sistema sanitario nei territori di Bergamo e Brescia 215
Analisi della variazione del burden dell’inquinamento atmosferico in Italia dal 1990 al 2019: evidenze dai dati del Global Burden of Disease Study 211
Risk management and drug utilization research 204
Patterns and trends of idarucizumab use in an Italian region: A probabilistic record-linkage approach in a real-life setting 204
Valutazione della prognosi nei soggetti ospedalizzati con COVID-19 in relazione all’utilizzo pregresso di statine: uno studio osservazionale condotto nelle ATS di Bergamo e Brescia 195
Respiratory Syncytial Virus (RSV) and Intention to Recommend RSV Vaccination: A Cross-Sectional Survey of Cardiologists and Cardiac Nurses in Southern Italy 187
Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 186
The burden of injury in Central, Eastern, and Western European sub-region: a systematic analysis from the Global Burden of Disease 2019 Study 180
Impact of covid-19 lockdown, during the two waves, on drug use and emergency department access in people with epilepsy: An interrupted time-series analysis 177
A Multidatabase study of trajectories of antidepressant use in Italy 171
Time trends in the incidence of essential tremor: Evidences from UK and France primary care data 170
Does smoking have an impact on the immunological response to COVID-19 vaccines? Evidence from the VASCO study and need for further studies 165
Impatto dell’epidemia SARS-COV2 sulla gestione dei pazienti affetti da epilessia: un’analisi delle serie storiche interrotte sull’uso degli antiepilettici e l’accesso in pronto soccorso durante le due ondate COVID-19 159
Human papillomavirus vaccine and demyelinating diseases—A systematic review and meta-analysis 144
Raphanus sativus cv. Sango sprout juice decreases diet-induced obesity in sprague dawley rats and ameliorates related disorders 141
Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region 140
Myopathy with DPP-4 inhibitors and statins in the real world: investigating the likelihood of drug–drug interactions through the FDA adverse event reporting system 139
Prevalence and determinants of long-term utilization of antidepressant drugs: A retrospective cohort study 136
Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping 135
Assessment of adverse reactions to α-lipoic acid containing dietary supplements through spontaneous reporting systems 134
Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up—Reply 133
The Burden of Chronic Heart Failure in Primary Care in Italy 133
Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System 132
Dynamics of antibody response to BNT162b2 mRNA COVID-19 vaccine after 6 months 130
Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System 129
Editorial: Overcoming boundaries in public health: Advances in international and global health 129
Diabetes is associated with decreased migraine risk: A nationwide cohort study 128
Assessing intravitreal anti-VEGF drug safety using real-world data: methodological challenges in observational research 127
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System 123
Use of antidepressants and the risk of Parkinson's disease in the Local Health Trust of Bologna: A historical cohort study 123
Digestibility, toxicity and metabolic effects of rapeseed and sunflower protein hydrolysates in mice 122
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy 122
Drug-induced Kounis syndrome: A matter of pharmacovigilance 121
Serious Cutaneous Toxicities with Immune Checkpoint Inhibitors in the U.S. Food and Drug Administration Adverse Event Reporting System 120
Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System 114
Real-world evidence and pharmacovigilance: workshop of the Italian Epidemiological Association and of the Italian Society of Pharmacology 113
Use of antidepressants during COVID19 outbreak: a real-world drug-utilization study 111
Signal of potentially protective drug–drug interactions from spontaneous reporting systems: proceed with caution 110
Overview of the European post-authorisation study register post-authorization studies performed in Europe from September 2010 to December 2018 110
Adverse events with sacubitril/valsartan in the real world: Emerging signals to target preventive strategies from the FDA adverse event reporting system 108
Drug-induced systemic lupus erythematosus: Should immune checkpoint inhibitors be added to the evolving list? 107
Timing of hepatitis B and C virus elimination in Europe: a picture from the Global Burden of Disease Study 2019 95
Reply-Letter to the editor - The valuable support of spontaneous reporting systems in exploring safety profile of dietary supplements 93
Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres 90
Totale 17.346
Categoria #
all - tutte 61.174
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.174


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022314 0 0 0 39 49 20 46 23 21 32 37 47
2022/2023834 44 211 69 45 71 72 158 39 41 25 24 35
2023/20241.358 42 80 71 123 162 262 139 64 127 44 105 139
2024/20253.445 173 332 133 189 287 180 249 120 368 490 328 596
2025/20268.248 1.310 790 581 878 816 398 1.108 324 569 637 304 533
2026/20272.671 322 404 815 1.130 0 0 0 0 0 0 0 0
Totale 17.346